摘要:
A message center that can comprise a liquid crystal display (LCD) is provided. The LCD can be divided into one or more zones, with each zone being designated for a specific message. The message center can also include a light guide system positioned behind the liquid crystal display. The light guide system can have one or more light guides, with each of the light guides having a first end, and each of the light guides can be aligned with a zone of the liquid crystal display. The message center can further include a multi-color light emitting diode (LED) that can be mounted at the first end of each of the light guides, and a control system that can set the intensity of each of the multi-colors on each of the LEDs such that a backlighting of each zone is individually controlled.
摘要:
A system is disclosed for correcting a color of light being generated by an LCD image system having an LED and an LCD glass component that is illuminated by the LED. A plurality of color correction filters are constructed, with each providing a predetermined, differing color shift to light being output by the LCD glass component, based on a measured color of the light being output from the LCD glass component. Each of the color correction filters is constructed based on a known range of color variations that may be present in a color of the light being output from the LCD glass component. Each filter provides a color shift that shifts the color of the light being output from the LCD glass component from outside a predetermined target color area back into the predetermined target color area.
摘要:
The present invention provides vacuolar-type (H+)-ATPase-inhibiting compounds, compositions thereof, and methods of using them to treat or prevent a condition treatable by the inhibition of a vacuolar-type (H+)-ATPase. The composition of the present invention comprises a compound of the present invention and a carrier. The method of the present invention includes administering a vacuolar-type (H+)-ATPase inhibiting-effective amount of a compound of the present invention. The compound of the present invention has formula (I) wherein R1 and R2 are H, saturated or unsaturated alkyl, aryl, R6CH2—, R6CO—, or R6SO2—, wherein R6 is H, saturated or unsaturated alkyl, or aryl; R3 is H, alkyl, aryl, an oxime, or an oxime methyl ether; the aromatic ring is unsubstituted or substituted; and Z is a contiguous linker comprising a chain of 0-10 atoms which, together with the five atoms beginning with the carbon of the aromatic ring in meta-relationship with OR1 and ending with the carbon directly attached to the alkyl oxygen of the lactone, integrally form a 5-17 membered ring; or a pharmaceutically acceptable salt, an ester, or a prodrug thereof.
摘要:
A system and method for interfacing video devices over a link where electronic digital video data having a quantity (n) of bits of parallel data transmitted electronically at a first clock rate (R1) is converted to a stream of electronic serial data that is transmitted a second clock rate (R2=R1×n). The stream of electronic serial data is transmitted over a link that can be a fiber optic link or include one or more conductors. A receiver is employed to convert the data transmitted over the link into an output data stream having (n) bits of parallel data transmitted electronically at the first clock rate (R1). If the link is a fiber optic link, the receiver can convert the data transmitted over the link into to a second stream electronic serial data that is transmitted at the second clock rate (R2) and then to the output data stream.
摘要翻译:一种用于通过链路来连接视频设备的系统和方法,其中具有以第一时钟速率(R 1> 1)以电子方式发送的并行数据量的数量(n)的电子数字视频数据被转换为流 以及第二时钟速率(R 2 2 = R 1 x n)的电子串行数据。 电子串行数据流通过可以是光纤链路的链路传输,或者包括一个或多个导体。 采用接收机将通过链路发送的数据转换成具有以第一时钟速率(R 1> 1)电子发送的(n)个并行数据位的输出数据流。 如果链路是光纤链路,则接收机可以将通过链路传输的数据转换成以第二时钟速率(R 2> 2)发送的第二流电子串行数据,然后到 输出数据流。
摘要:
The present invention provides antiviral proteins, peptides and conjugates, as well as methods of obtaining these agents. The antiviral proteins, peptides and conjugates of the present invention can be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection.
摘要:
The present invention provides new monomeric derivatives of the C-8'-7 linked naphthylisoquinoline alkaloid dioncophylline D. The invention also provides new C-4 substituted monomeric arylisoquinoline alkaloid derivatives. The present invention furthermore provides novel dimeric arylisoquinoline alkaloids comprised of coupled first and second arylisoquinoline monomers, wherein either or both of said monomer(s) is (are) monomeric compound(s) of the present invention. Monomeric and dimeric compounds of the present invention have medically useful properties, such as antimicrobial properties, more specifically such as antimalarial and antiviral properties. Monomeric compounds of the present invention are also useful as building blocks or intermediates for synthesis of novel dimeric arylisoquinoline alkaloids. Monomeric and dimeric compounds of the present invention may be obtained in substantially pure form by total synthesis, partial synthesis, or derivatization from known synthetic or naturally occurring compounds, and by isolation and purification from plants of the Dioncophyllaceae and Ancistrocladaceae families.
摘要:
The present invention provides antiviral proteins (collectively referred to as cyanovirins), conjugates thereof, DNA sequences ending such agents, host cells containing such DNA sequences, antibodies directed to such agents, compositions comprising such agents, and methods of obtaining and using such agents.
摘要:
The present invention provides novel antiviral naphthoquinone compounds, which may be isolated from plants of the genus Conospermum or synthesized chemically, in accordance with the present inventive methods. The antiviral naphthoquionone compounds, derivatives thereof, and prodrugs thereof, may be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the growth or replication of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection.
摘要:
The present invention provides antiviral proteins, peptides and conjugates, as well as methods of obtaining these agents. The antiviral proteins, peptides and conjugates of the present invention can be used alone or in combination with other antiviral agents in compositions, such as pharmaceutical compositions, to inhibit the infectivity, replication and cytopathic effects of a virus, such as a retrovirus, in particular a human immunodeficiency virus, specifically HIV-1 or HIV-2, in the treatment or prevention of viral infection.
摘要:
The present invention provides methods of preparing dimeric naphthylisoquinoline alkaloids by coupling together two monomeric naphthylisoquinoline alkaloids, each of which may be the same or different, and one, both, or neither of which may possess a C-8' to C-5 naphthalene/isoquinoline linkage, to form homodimers or heterodimers, including the antiviral michellamines. The present invention also provides new, medically useful homodimeric and heterodimeric naphthylisoquinoline compounds and derivatives thereof.